Related Experiment Video

Updated: Jul 14, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

SERCA2a, phospholamban, sarcolipin, and ryanodine receptors gene expression in children with congenital heart defects

Simona Vittorini1, Simona Storti, Maria Serena Parri

  • 1Molecular Cardiology and Genetics Laboratory, Institute of Clinical Physiology, National Research Council, G Pasquinucci Hospital, Massa, Italy. simona.vittorini@ifc.cnr.it

Molecular Medicine (Cambridge, Mass.)
|May 23, 2007
PubMed

Insights

Children with Tetralogy of Fallot (TOF) show lower expression of phospholamban (PLN) and sarcolipin (SLN) genes. This suggests a mechanism to increase intracellular calcium in TOF patients, impacting heart function.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Pediatric Heart Disease Research

Background:

  • Conotruncal heart defects are associated with abnormal calcium handling in animal models.
  • Sarcoplasmic reticulum Ca(2+) ATPase (SERCA), phospholamban (PLN), sarcolipin (SLN), and ryanodine receptors (RyRs) are critical for intracellular calcium regulation in the heart.
  • Understanding gene expression of these proteins in human congenital heart disease is crucial for therapeutic insights.

Purpose of the Study:

  • To investigate the gene expression of SERCA2a, PLN, SLN, and RyR2 in pediatric patients with Tetralogy of Fallot (TOF).
  • To compare gene expression patterns in TOF patients with those having Ventricular Septal Defect (VSD) and Atrial Septal Defect (ASD).

Main Methods:

  • Semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to assess gene expression.
  • Atrial myocardium samples were analyzed from 23 pediatric patients with TOF, 10 with VSD, and 13 with ASD.
  • Calsequestrin (CASQ) RNA served as the internal standard for normalization.

Main Results:

  • Significantly lower expression of PLN and SLN genes was observed in patients with TOF compared to controls.
  • No significant differences in SERCA2a and RyR2 gene expression were found between TOF and VSD groups.
  • These findings indicate altered calcium regulatory protein expression in TOF.

Conclusions:

  • The reduced expression of PLN and SLN in TOF patients may represent a compensatory mechanism.
  • This mechanism likely aims to enhance intracellular calcium (Ca2+) availability and cardiac contractility in TOF.
  • Further research is needed to elucidate the full implications of these molecular changes in pediatric heart defects.

More Related Videos

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...